{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T20:03:46Z","timestamp":1774728226180,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["12\/IA\/1667"],"award-info":[{"award-number":["12\/IA\/1667"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijrobp.2025.09.034","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:41:37Z","timestamp":1758631297000},"page":"702-716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evolutionary Double-Bind Treatment Using Radiation Therapy and Natural Killer Cell-Based Immunotherapy in Prostate Cancer"],"prefix":"10.1016","volume":"124","author":[{"given":"Kimberly A.","family":"Luddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Robertson-Tessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bina","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor M.","family":"Bursell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacintha","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Marignol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Gatenby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander R.A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cliona","family":"O\u2019Farrelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.09.034_bib0001","series-title":"Cancer facts & figures 2023","year":"2023"},{"issue":"1","key":"10.1016\/j.ijrobp.2025.09.034_bib0002","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40164-023-00444-9","article-title":"Recent advances and future perspectives in the therapeutics of prostate cancer","volume":"12","author":"Varaprasad","year":"2023","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"10.1016\/j.ijrobp.2025.09.034_bib0003","doi-asserted-by":"crossref","first-page":"667","DOI":"10.20517\/cdr.2022.15","article-title":"Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo","volume":"5","author":"Yehya","year":"2022","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100962","article-title":"Current therapy and drug resistance in metastatic castration-resistant prostate cancer","volume":"68","author":"Cai","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0005","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.76284","article-title":"Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes","volume":"11","author":"Zhang","year":"2022","journal-title":"elife"},{"issue":"17","key":"10.1016\/j.ijrobp.2025.09.034_bib0006","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.3390\/cancers13174448","article-title":"Darwinian approaches for cancer treatment: benefits of mathematical modeling","volume":"13","author":"Belkhir","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0007","series-title":"Ecology and Evolution of Cancer","first-page":"193","article-title":"Applying tools from evolutionary biology to cancer research","author":"Enriquez-Navas","year":"2017"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0008","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jtbi.2018.07.028","article-title":"Capitalizing on competition: an evolutionary model of competitive release in metastatic castration resistant prostate cancer treatment","volume":"455","author":"West","year":"2018","journal-title":"J Theor Biol"},{"issue":"327","key":"10.1016\/j.ijrobp.2025.09.034_bib0009","doi-asserted-by":"crossref","first-page":"327ra24","DOI":"10.1126\/scitranslmed.aad7842","article-title":"Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer","volume":"8","author":"Enriquez-Navas","year":"2016","journal-title":"Sci Transl Med"},{"issue":"7246","key":"10.1016\/j.ijrobp.2025.09.034_bib0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/459508a","article-title":"A change of strategy in the war on cancer","volume":"459","author":"Gatenby","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ijrobp.2025.09.034_bib0011","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-022-00454-5","article-title":"Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer","volume":"22","author":"Labrie","year":"2022","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"10.1016\/j.ijrobp.2025.09.034_bib0012","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1158\/0008-5472.CAN-09-1354","article-title":"Lessons from applied ecology: cancer control using an evolutionary double bind","volume":"69","author":"Gatenby","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ijrobp.2025.09.034_bib0013","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1021\/mp200458e","article-title":"Exploiting evolution to treat drug resistance: combination therapy and the double bind","volume":"9","author":"Basanta","year":"2012","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.ijrobp.2025.09.034_bib0014","first-page":"199","article-title":"Predator facilitation\u2014the combined effect of snakes and owls on the foraging behavior of Gerbils","volume":"29","author":"Kotler","year":"1992","journal-title":"Ann Zool Fenn"},{"issue":"3","key":"10.1016\/j.ijrobp.2025.09.034_bib0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2005.06.032","article-title":"Combining radiotherapy and immunotherapy: a revived partnership","volume":"63","author":"Demaria","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ijrobp.2025.09.034_bib0016","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and immunotherapy: a beneficial liaison?","volume":"14","author":"Weichselbaum","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"10.1016\/j.ijrobp.2025.09.034_bib0017","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/cells8091105","article-title":"Cellular stress responses in radiotherapy","volume":"8","author":"Kim","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ijrobp.2025.09.034_bib0018","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/0008-5472.CAN-15-1423","article-title":"Abscopal benefits of localized radiotherapy depend on activated T-cell trafficking and distribution between metastatic lesions","volume":"76","author":"Poleszczuk","year":"2016","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ijrobp.2025.09.034_bib0019","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ijrobp.2023.12.046","article-title":"The next chapter in immunotherapy and radiation combination therapy: cancer-specific perspectives","volume":"118","author":"Wisdom","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7054","key":"10.1016\/j.ijrobp.2025.09.034_bib0020","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0021","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2013.00508","article-title":"The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells","volume":"4","author":"Cerboni","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.896228","article-title":"All about (NK cell-mediated) death in two acts and an unexpected encore: initiation, execution and activation of adaptive immunity","volume":"13","author":"Ram\u00edrez-Labrada","year":"2022","journal-title":"Front Immunol"},{"issue":"30","key":"10.1016\/j.ijrobp.2025.09.034_bib0023","doi-asserted-by":"crossref","first-page":"47163","DOI":"10.18632\/oncotarget.9980","article-title":"Fas ligand and lytic granule differentially control cytotoxic dynamics of natural killer cell against cancer target","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ijrobp.2025.09.034_bib0024","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3799","article-title":"Balancing natural killer cell activation through paired receptors","volume":"15","author":"Martinet","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"17","key":"10.1016\/j.ijrobp.2025.09.034_bib0025","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.3390\/ijms20174131","article-title":"Hepatic tumor microenvironments and effects on NK cell phenotype and function","volume":"20","author":"Pineiro Fernandez","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0026","first-page":"73","article-title":"Natural killer cells: role in local tumor growth and metastasis","volume":"6","author":"Langers","year":"2012","journal-title":"Biologics"},{"issue":"9","key":"10.1016\/j.ijrobp.2025.09.034_bib0027","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0028","first-page":"115","article-title":"NK cells and cancer immunoediting","volume":"395","author":"Guillerey","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.921447","article-title":"Evolutionary selection identifies critical immune-relevant genes in lung cancer subtypes","volume":"13","author":"Luddy","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2022.111172","article-title":"T cell therapy against cancer: a predictive diffuse-interface mathematical model informed by pre-clinical studies","volume":"547","author":"Pozzi","year":"2022","journal-title":"J Theor Biol"},{"issue":"21","key":"10.1016\/j.ijrobp.2025.09.034_bib0031","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.3390\/cancers13215314","article-title":"An agent-based model of combination oncolytic viral therapy and anti-PD-1 immunotherapy reveals the importance of spatial location when treating glioblastoma","volume":"13","author":"Storey","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ijrobp.2025.09.034_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001387","article-title":"In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity","volume":"9","author":"Jenner","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.ijrobp.2025.09.034_bib0033","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s11538-018-0424-4","article-title":"Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols","volume":"80","author":"Jenner","year":"2018","journal-title":"Bull Math Biol"},{"issue":"1","key":"10.1016\/j.ijrobp.2025.09.034_bib0034","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13014-025-02626-7","article-title":"Mathematical modeling in radiotherapy for cancer: a comprehensive narrative review","volume":"20","author":"Zheng","year":"2025","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ijrobp.2025.09.034_bib0035","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1038\/s41598-018-27718-1","article-title":"Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy","volume":"8","author":"Walker","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100796","article-title":"Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system","volume":"28","author":"Bekker","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0037","doi-asserted-by":"crossref","DOI":"10.1038\/srep34796","article-title":"Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells","volume":"6","author":"McDermott","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ijrobp.2025.09.034_bib0038","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13235-021-00397-w","article-title":"The contribution of evolutionary game theory to understanding and treating cancer","volume":"12","author":"Wolfl","year":"2022","journal-title":"Dyn Games Appl"},{"issue":"3","key":"10.1016\/j.ijrobp.2025.09.034_bib0039","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41559-018-0768-z","article-title":"Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer","volume":"3","author":"Kaznatcheev","year":"2019","journal-title":"Nat Ecol Evol"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0040","doi-asserted-by":"crossref","unstructured":"Emond R, Griffiths JI, Grolmusz VK, et al. Ecological interactions in breast cancer: cell facilitation promotes growth and survival under drug pressure. bioRxiv, Preprint posted online February 1. 2021. doi:10.1101\/2021.02.01.429214.","DOI":"10.1101\/2021.02.01.429214"},{"issue":"8","key":"10.1016\/j.ijrobp.2025.09.034_bib0041","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/oik.06957","article-title":"An empiricist\u2019s guide to modern coexistence theory for competitive communities","volume":"129","author":"Godwin","year":"2020","journal-title":"Oikos"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00078","article-title":"The immune checkpoint kick start: optimization of neoadjuvant combination therapy using game theory","volume":"3","author":"West","year":"2019","journal-title":"JCO Clin Cancer Inform"},{"issue":"8","key":"10.1016\/j.ijrobp.2025.09.034_bib0043","doi-asserted-by":"crossref","first-page":"E1709","DOI":"10.1073\/pnas.1719031115","article-title":"Effective games and the confusion over spatial structure","volume":"115","author":"Kaznatcheev","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ijrobp.2025.09.034_bib0044","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s42003-020-01529-5","article-title":"Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancer","volume":"4","author":"Paczkowski","year":"2021","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.ijrobp.2025.09.034_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10863-007-9085-y","article-title":"Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?","volume":"39","author":"Gillies","year":"2007","journal-title":"J Bioenerg Biomembr"},{"issue":"7","key":"10.1016\/j.ijrobp.2025.09.034_bib0046","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrc3298","article-title":"Evolutionary dynamics of carcinogenesis and why targeted therapy does not work","volume":"12","author":"Gillies","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.ijrobp.2025.09.034_bib0047","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrg3922","article-title":"Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms","volume":"16","author":"Hughes","year":"2015","journal-title":"Nat Rev Genet"},{"issue":"3","key":"10.1016\/j.ijrobp.2025.09.034_bib0048","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PPO.0b013e318292e4e3","article-title":"Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer","volume":"19","author":"Willers","year":"2013","journal-title":"Cancer J"},{"issue":"10","key":"10.1016\/j.ijrobp.2025.09.034_bib0049","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.3390\/cancers12102916","article-title":"Tumor microenvironment as a regulator of radiation therapy: new insights into stromal-mediated radioresistance","volume":"12","author":"Krisnawan","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ijrobp.2025.09.034_bib0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.mcm.2007.02.032","article-title":"Metamodeling tumor\u2013immune system interaction, tumor evasion and immunotherapy","volume":"47","author":"d\u2019Onofrio","year":"2008","journal-title":"Math Comput Model"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0051","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","article-title":"The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway","volume":"79","author":"Lieber","year":"2010","journal-title":"Annu Rev Biochem"},{"issue":"7267","key":"10.1016\/j.ijrobp.2025.09.034_bib0052","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ijrobp.2025.09.034_bib0053","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/cancers12061367","article-title":"PSMA theranostics: review of the current status of PSMA-targeted imaging and radioligand therapy","volume":"12","author":"Jones","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0054","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231157632","article-title":"Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials","volume":"15","author":"Jang","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0055","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3389\/fonc.2020.00874","article-title":"Immunomodulation of NK cells by ionizing radiation","volume":"10","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0056","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jtbi.2019.03.002","article-title":"Mathematical modeling of tumor-immune cell interactions","volume":"469","author":"Mahlbacher","year":"2019","journal-title":"J Theor Biol"},{"issue":"17","key":"10.1016\/j.ijrobp.2025.09.034_bib0057","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1158\/0008-5472.CAN-15-3567","article-title":"Mathematical modeling of cancer immunotherapy and its synergy with radiotherapy","volume":"76","author":"Serre","year":"2016","journal-title":"Cancer Res"},{"issue":"1-2","key":"10.1016\/j.ijrobp.2025.09.034_bib0058","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral sensitivity as a strategy against cancer multidrug resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resist Updat"},{"issue":"9","key":"10.1016\/j.ijrobp.2025.09.034_bib0059","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.3390\/ijms21093333","article-title":"MRP1-collateral sensitizers as a novel therapeutic approach in resistant cancer therapy: an in vitro and in vivo study in lung resistant tumor","volume":"21","author":"Riganti","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ijrobp.2025.09.034_bib0060","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1158\/0008-5472.CAN-20-0806","article-title":"Turnover modulates the need for a cost of resistance in adaptive therapy","volume":"81","author":"Strobl","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.09.034_bib0061","doi-asserted-by":"crossref","unstructured":"Susswein Z, Sengupta S, Clarke R, Bansal S. Borrowing ecological theory to infer interactions between sensitive and resistant breast cancer cell populations. bioRxiv, Preprint. doi:10.1101\/2022.02.18.481041.","DOI":"10.1101\/2022.02.18.481041"},{"issue":"1","key":"10.1016\/j.ijrobp.2025.09.034_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004689","article-title":"Does high-dose antimicrobial chemotherapy prevent the evolution of resistance?","volume":"12","author":"Day","year":"2016","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"10.1016\/j.ijrobp.2025.09.034_bib0063","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41559-016-0050","article-title":"The unconstrained evolution of fast and efficient antibiotic-resistant bacterial genomes","volume":"1","author":"Reding-Roman","year":"2017","journal-title":"Nat Ecol Evol"},{"issue":"2","key":"10.1016\/j.ijrobp.2025.09.034_bib0064","doi-asserted-by":"crossref","first-page":"nwaa124","DOI":"10.1093\/nsr\/nwaa124","article-title":"Variation in the life history strategy underlies functional diversity of tumors","volume":"8","author":"Li","year":"2021","journal-title":"Natl Sci Rev"},{"issue":"12","key":"10.1016\/j.ijrobp.2025.09.034_bib0065","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrc3606","article-title":"Life history trade-offs in cancer evolution","volume":"13","author":"Aktipis","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.ijrobp.2025.09.034_bib0066","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","article-title":"Adaptive therapy","volume":"69","author":"Gatenby","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ijrobp.2025.09.034_bib0067","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41559-021-01428-w","article-title":"A theoretical analysis of tumour containment","volume":"5","author":"Viossat","year":"2021","journal-title":"Nat Ecol Evol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625062935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625062935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:44:55Z","timestamp":1773265495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625062935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0360301625062935"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.09.034","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolutionary Double-Bind Treatment Using Radiation Therapy and Natural Killer Cell-Based Immunotherapy in Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}